BioSpace News Archive

Medexus Pharmaceuticals Inc. announced today that it has initiated its first commercial shipment of Trecondyv® (treosulfan) in Canada.

Life Sciences BC will be celebrating the BC life sciences sector and community at the 23rd Annual Life Sciences BC Awards, presented by FARRIS at 2pm PT on Thursday September 23, 2021.

ImmuneID, Inc. today announced the appointment of James S. Scibetta as Chief Executive Officer and a member of the Board of Directors.

- Licensed Candidates Hold Potential to Address Emerging SARS-CoV-2 and other Infectious Diseases Including Human and Veterinary Applications -

CytoDyn Inc. today announced that Dr. Scott Kelly, CytoDyn’s Chairman of the Board, Chief Medical Officer and Head of Business Development, will be presenting at the World Antiviral Congress 2021.

Biocept to Present Data at RAS-Targeted Drug Development Summit Showing Ability of Its Switch-Blocker TM Technology to Detect Rare Cancer Mutations

Longboard Pharmaceuticals, Inc. (Nasdaq: LBPH), a clinical-stage biopharmaceutical company focused on developing novel, transformative medicines for neurological diseases, today announced that members of its senior leadership team will present in a fireside chat format at the Cantor Virtual Global Healthcare Conference on September 28, 2021.

Nemaura Medical, Inc. (NASDAQ: NMRD), a medical technology company focused on developing and commercializing non-invasive wearable diagnostic devices and supporting personalized lifestyle coaching programs, announces today that Chief Executive Officer Faz Chowdhury, Ph.D. will present at the Benzinga Healthcare Small Cap Conference.

Brooklyn ImmunoTherapeutics, Inc. (NYSE American: BTX) (“Brooklyn”), today provided highlights from a Shareholder Update Call conducted on September 20, 2021 by President and Chief Executive Officer Howard J. Federoff, M.D., Ph.D., with guest contributor Matt Angel, Ph.D., Factor Bioscience’s Co-founder and Chief Executive Officer.

Evaxion Biotech A/S announced today it has promoted its Senior Director, Immuno-Oncology, Birgitte Rønø, Ph.D, to the newly-created position of Chief Scientific Officer, effective immediately.